. 2023 Feb 21;8(2):100878. doi: 10.1016/j.esmoop.2023.100878

Table 1.

Examples of real-world data (RWD) studies. Selected examples cited by the participating cooperative groups of RWD studies that they had initiated

Cooperative group	Name of study	Primary objective	Country	Design	Reference
AGITG	RESOLUTE	To assess the clinical benefit of local ablative therapy following initial standard first-line systemic treatment compared with continued standard first-line systemic treatment in patients with unresectable oligometastatic colorectal cancer	Australia	Registry-based trial	⁴⁷
ARCAGY-GINECO	ENCOURAGE	To assess the safety profile of first-line bevacizumab therapy for ovarian cancer	France	Prospective cohort study	⁴⁸
ISG	TrObs	To evaluate the treatment outcomes of patients with advanced soft tissue sarcomas receiving trabectedin	Italy	Retrospective cohort study	⁴⁹
KGOG	KGOG 3052	To compare survival outcomes between bevacizumab and olaparib maintenance therapy for BRCA-mutated, platinum-sensitive relapsed high-grade serous ovarian carcinoma	South Korea	Retrospective cohort study	⁵⁰
LACOG	LACOG 0319	To evaluate the quality of life of patients with recurrent or metastatic squamous cell carcinoma of the head and neck receiving nivolumab	Brazil	Prospective cohort study	⁵¹

AGITG, Australasian Gastro-Intestinal Trials Group; ARCAGY-GINECO, Association de Recherche sur les Cancers dont Gynécologiques - Groupe d’Investigateurs Nationaux pour l’Étude des Cancers Ovariens et du sein; ISG, Italian Sarcoma Group; KGOG, Korean Gynecologic Oncology Group; LACOG, Latin American Cooperative Oncology Group.